Rosenthal S A, Hait W N
Department of Medicine, Yale University School of Medicine, New Haven, CT 06510.
Yale J Biol Med. 1988 Jan-Feb;61(1):39-49.
Many physical and chemical agents used in anti-neoplastic therapy are known to act by effecting DNA damage. The possibility that calmodulin may be an important modulator of the response to DNA damage in eukaryotic cells has been explored in a number of studies which use calmodulin antagonists in combination with agents known to damage DNA. We review these studies and discuss the therapeutic potential of calmodulin antagonists in combination therapy.
已知许多用于抗肿瘤治疗的物理和化学药物通过造成DNA损伤来发挥作用。在一些研究中,人们探索了钙调蛋白可能是真核细胞中对DNA损伤反应的重要调节因子这一可能性,这些研究将钙调蛋白拮抗剂与已知会损伤DNA的药物联合使用。我们回顾了这些研究,并讨论了钙调蛋白拮抗剂在联合治疗中的治疗潜力。